📰 Published December News
Published December News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Published December. Real-time updates on events, politics, business and more.
June 11, 2024
Read the latest stories and columns from staff writer Seth J. Frantzman in The Washington Times.
May 21, 2024
Inavolisib was submitted to the FDA for review as a first-line treatment for advanced HR-positive, HER2-negative PIK3CA-mutated breast cancer.
May 19, 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
May 16, 2024
From the prospect of semaglutide and MDMA for substance use disorder to evolving research around personality disorders and OCD, here are 5 key topics from the annual psychiatric meeting.
May 6, 2024
Lykos Therapeutics' new drug application for MDMA plus psychiatric intervention for adults with PTSD will be the first reviewed by an FDA committee for such a therapy.
March 24, 2024
A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.
February 21, 2024
Natural gas prices went up once again, as the authorities take nothing for chance under the IMF SBA conditions. The...
February 7, 2024
A new technique that takes a chemical fingerprint of gin in seconds could hold 'huge potential' for the industry: allowing producers to create better and more consistent gins; enable regulators to detect fraudulent products; and even help create a stronger definition of what a gin is.
February 6, 2024
A new technique that takes a chemical fingerprint of gin in seconds could hold 'huge potential' for the industry: allowing producers to create better gins; enable regulators to detect fraudulent products; and even help create a stronger definition of what a gin actually is.
January 18, 2024
Accelus has announced the closing of a $20 million debt facility with Symbiotic Capital....